DalsnaFinance

FDA accepts Genentech filing for Tecentriq in colon cancer

Markets Investing.com By Investing.com 11 Jun 2026 05:09 1 min read
FDA accepts Genentech filing for Tecentriq in colon cancer

FDA accepts Genentech filing for Tecentriq in colon cancer

FDA accepts Genentech filing for Tecentriq in colon cancer

Read the full story on Investing.com → Opens the original article on www.investing.com

Summary aggregated from Investing.com's public RSS feed. The full reporting belongs to Investing.com — please read it on their site.